US breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 9.3% during the forecast period. The factors that enabling the growth of the market includes the prevalence of breast cancer and the initiative by the government and private organization. Breast cancer is the most commonly diagnosed cancer type in the […]
